SPDR S&P Pharmaceuticals ETF
XPH
XPH
78 hedge funds and large institutions have $149M invested in SPDR S&P Pharmaceuticals ETF in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 22 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $167M → $149M (-$18.7M)
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $687K
Holders
78
Holding in Top 10
–
Calls
$1K
Puts
$687K
Top Buyers
| 1 | +$7.71M | |
| 2 | +$6.31M | |
| 3 | +$2.76M | |
| 4 |
Citigroup
New York
|
+$2.52M |
| 5 |
RCM
RNC Capital Management
Los Angeles,
California
|
+$1.83M |
Top Sellers
| 1 | -$9.37M | |
| 2 | -$8.27M | |
| 3 | -$4.75M | |
| 4 |
KHLMTHM
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet
Tel Aviv,
Israel
|
-$1.85M |
| 5 |
CCMD
Cypress Capital Management (Delaware)
Greenville,
Delaware
|
-$1.81M |